Literature DB >> 807672

Studies on the selective lysis and purification of Trypanosoma cruzi.

N Nogueira, C Bianco, Z Cohn.   

Abstract

The mechanism by which culture forms of Trypanosoma cruzi are lysed by normal mammalian sera was examined. Lysis is restricted to the epimastigote form of the organism and is not dependent on the presence of agglutinins. Lysis is a complement-dependent process, the activity being generated by the alternate pathway. The selective lysis by serum was exploited to purify viable trypomastigotes by means of centrifugation in an albumin column. Essentially pure trypomastigote populations are now being employed in cell culture experiments.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807672      PMCID: PMC2189871          DOI: 10.1084/jem.142.1.224

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Stearic acid, an essential growth factor for Trypanosoma cruzi.

Authors:  G J BONE; G PARENT
Journal:  J Gen Microbiol       Date:  1963-05

2.  [Lytic effect of normal sera on cultured and sanguineous forms of Trypanosoma cruzi].

Authors:  M RUBIO
Journal:  Bol Chil Parasitol       Date:  1956 Oct-Dec

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense.

Authors:  E J TOBIE; T VON BRAND; B MEHLMAN
Journal:  J Parasitol       Date:  1950-02       Impact factor: 1.276

5.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Authors:  D B Budzko; M C Pizzimenti; F Kierszenbaum
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

7.  Role of complement in immune lysis of Trypanosoma cruzi.

Authors:  D F Anziano; A P Dalmasso; R Lelchuk; C Vásquez
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

8.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

9.  Comparative bactericidal activities of blood serum and plasma serum.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-07-01       Impact factor: 14.307

  9 in total
  49 in total

Review 1.  Complement evasion by parasites: search for "Achilles' heel".

Authors:  Z Fishelson
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Apparent generation of a segmented mRNA from two separate tandem gene families in Trypanosoma cruzi.

Authors:  A Gonzalez; T J Lerner; M Huecas; B Sosa-Pineda; N Nogueira; P M Lizardi
Journal:  Nucleic Acids Res       Date:  1985-08-26       Impact factor: 16.971

3.  Activation of the alternative pathway of complement by Entamoeba histolytica.

Authors:  L Ortiz-Ortiz; R Capin; N R Capin; B Sepúlveda; G Zamacona
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

4.  Trypanosoma cruzi: metabolic labeling of trypomastigote sialoglycolipids.

Authors:  A S Couto; B Zingales; R M de Lederkremer; W Colli
Journal:  Experientia       Date:  1985-06-15

5.  Minichromosomal repetitive DNA in Trypanosoma cruzi: its use in a high-sensitivity parasite detection assay.

Authors:  A Gonzalez; E Prediger; M E Huecas; N Nogueira; P M Lizardi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi.

Authors:  E V Caler; S Vaena de Avalos; P A Haynes; N W Andrews; B A Burleigh
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Complement in experimental Trypanosoma lewisi infection of rats.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms.

Authors:  L A Hernández-Osorio; C Márquez-Dueñas; L E Florencio-Martínez; G Ballesteros-Rodea; S Martínez-Calvillo; R G Manning-Cela
Journal:  J Biomed Biotechnol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.